Immuno-oncology: State of the art I Educational session

ImmTACTM Platform: Novel bispecific high affinity TCR-effector fusions to modulate the immune system for the treatment of cancer (ID 105)

Lecture Time
10:10 - 10:30
Speakers
  • L. Humbert (Abingdon, United Kingdom)
Session Name
Immuno-oncology: State of the art I
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Authors
  • L. Humbert (Abingdon, United Kingdom)